Shop

Author at Microdose

Microdose

At our core, we champion integrity, diversity, and objectivity, providing trusted content that unites a wide array of experts and fosters unbiased opinions, ultimately empowering the psychedelic medicine community to flourish and make a positive impact on the world.

Press Releases

15 Mar 2021

Mindset Pharma Files a Sixth U.S. Provisional Patent, Further Expanding Its Psychedelic Drug Candidates Pipeline With Novel DMT & 5-MeO-DMT Analogs

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

12 Mar 2021

Ehave CEO Benjamin Kaplan to be Featured on Psychedelic Spotlight Segment of New to the Street Airing on NewsMax on Sunday March 14th at 10:00 AM EST and Fox Business March 15th at 7:30 PM EST

MIAMI, March 12, 2021 (GLOBE NEWSWIRE) — Ehave, Inc....

By Microdose

Press Releases

11 Mar 2021

Pure Extracts Sells First Shipment of Cannabis Oil Extracts to German Pharma Company

VANCOUVER, British Columbia, March 11, 2021 (GLOBE NEWSWIRE) — Pure Extracts Technologies Corp....

By Microdose

Press Releases

11 Mar 2021

New Wave Subsidiary, N2 Logics Enters Partnership Agreement with Toronto-Based Naturopathic Doctor, Dr. Elizabeth Goldspink, to Collaborate on…

TORONTO, March 11, 2021 /CNW/ – NEW WAVE HOLDINGS CORP....

By Microdose

Join Our Newsletter for Exclusive Updates, Stories, and More

Press Releases

11 Mar 2021

NeonMind Engages Certara to Advance its Synthetic Psilocybin Drug Candidates for Obesity

Vancouver, British Columbia–(Newsfile Corp....

By Microdose

Press Releases

10 Mar 2021

Mydecine Innovations Group Announces Plans to Spin Out of its [U.S.] Cannabis Assets

*NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES DENVER, March 10, 2021 (GLOBE NEWSWIRE) — Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE:...

By Microdose

Press Releases

10 Mar 2021

Mindset Pharma to Present at the Stifel GMP Conference – Psychedelics: Addressing the Global Mental Health Crisis

Toronto, Ontario–(Newsfile Corp....

By Microdose

Press Releases

10 Mar 2021

Microdose Announces the Launch of Accredited Course Series “The Science of Psychedelics: Training for Medical Professionals”

TORONTOMarch 10, 2021 /PRNewswire/ — Microdose is pleased to announce The Science of Psychedelics: Training for Medical Professionals, an online, accredited course series for physicians, psychologists, social workers, mental health...

By Microdose

Press Releases

10 Mar 2021

Pure Extracts Technologies Corp. Announces Listing of Warrants on the Canadian Securities Exchange Under the Symbol PULL.WT Commencing March 10, 2021

Not for distribution to United States newswire services or for release, publication, distribution ordissemination, directly or indirectly, in whole or in part, in or into the United States....

By Microdose

Follow us on social

Latest News

Trump’s Psychedelic Fast-Track Order Changes the Timeline. It Also Redraws the Competitive Map.

AbbVie Withdraws Patent Challenge, Clearing Path for Enveric’s Psychedelic IP Strategy

Breaking: Enveric Reports New Mechanistic Data Supporting Non-Hallucinogenic Neuroplastogen Strategy

You Might Also Like

17 Dec 2025

Psychedelics in 2025: A Year of Proof, Pullback, and a Clearer Path Forward

If 2024 was the year the psychedelic field learned how hard “approval ready” really is, 2025 was the year it began behaving accordingly. The past twelve months were less about...

By Madison Roberts

26 Nov 2025

Delix Therapeutics Reports Strong Phase Ib Results

Delix Therapeutics recently announced compelling data from a Phase Ib trial of DLX-001 (zalsupindole), a non-hallucinogenic neuroplastogen. According to the company’s release, DLX-001 produced robust biomarker signals (quantitative EEG and...

By Madison Roberts

19 Nov 2025

Childhood Trauma’s Role in Men’s Substance Use Disorders

Childhood trauma leaves a deeper imprint on men’s lives than most realize—and for many, it becomes the hidden engine driving substance use disorders. Research shows that emotional abuse, physical violence,...

By Madison Roberts

19 Nov 2025

Human-Centered AI in Healthcare

Artificial intelligence is redefining modern healthcare, offering powerful tools that enhance diagnosis, expedite drug discovery, and enable truly personalized treatment. As health systems struggle with rising costs, aging populations, and...

By Madison Roberts

16 Oct 2025

Enveric Biosciences Doubles Down on IP Strength as Psychedelic Biotech Sector Heats Up

As Big Pharma makes billion-dollar bets in the evolving landscape of neuropsychiatric therapeutics, Enveric Biosciences (NASDAQ: ENVB) is carving out a formidable position — not by chasing headlines, but by...

By Madison Roberts

15 Oct 2025

The IP Battle Behind the $1.2B Psychedelic Acquisition—and Why Enveric Biosciences Is a Name to Watch

Take Enveric Biosciences (NASDAQ: ENVB), a company that’s been flying under the radar while building an IP fortress around a novel class of non-hallucinogenic neuroplastogens. Now, that fortress is being...

By Madison Roberts
WordPress Ads
No Result
View All Result

© 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.